These findings suggest that the regulatory mechanisms governing sPD-1 and sPD-L1 expression and release are highly tumor-specific, emphasizing the complexity of their roles in cancer biology and the potential for differential biomarker utility across malignancies. Here, HOXD13 is linked to neoplasm.